Please provide your email address to receive an email when new articles are posted on . A novel SK ion channel inhibitor more often converted atrial fibrillation to sinus rhythm compared with placebo.
A research group led by Assistant Professor Megumi Aimoto and Professor Akira Takahara at the Faculty of Pharmaceutical Sciences, Toho University, revealed that pyrazole-3 (Pyr3), a selective ...
Verywell Health on MSN

Atrial fibrillation life expectancy

Medically reviewed by Jeffrey S. Lander, MD Key Takeaways Atrial fibrillation (AFib) can lead to strokes and heart failure, ...